Ignite Creation Date:
2025-12-24 @ 5:59 PM
Ignite Modification Date:
2026-03-03 @ 4:14 AM
Study NCT ID:
NCT06135168
Status:
COMPLETED
Last Update Posted:
2025-04-03
First Post:
2023-10-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations
Sponsor:
Changchun GeneScience Pharmaceutical Co., Ltd.
Organization:
Study Overview
Official Title:
A Single-center, Randomized, Open-label, Parallel Study to Compare the Pharmacokinetics of Two Polyethylene Glycol Recombinant Human Growth Hormone With Different Preparations by Single Subcutaneous Injection in Chinese Healthy Adult Male Subjects
Status:
COMPLETED
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the pharmacokinetics of the two different PEG-rhGH preparations after a single administration.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: